Brief: Surface Oncology Reports Financial Results And Corporate Highlights For First Quarter 2022
09/05/2022 12:27
May 9 (Reuters) - Surface Oncology Inc SURF.O :
* SURFACE ONCOLOGY REPORTS FINANCIAL RESULTS AND CORPORATE
HIGHLIGHTS FOR FIRST QUARTER 2022
* CASH RUNWAY EXTENDED INTO 2024
* EXPANDING OPEN LABEL LEAD-IN FOR SRF388 IN FIRST-LINE HCC,
WITH
INITIAL DATA EXPECTED IN FIRST HALF OF 2023
* QTRLY EARNINGS PER SHARE $0.13
* Q1 EARNINGS PER SHARE VIEW $-0.29 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX5B5Kw3
Further company coverage: SURF.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Surface Oncology
See all newsBrief: Surface Oncology Says Anticipates Will Have Net Cash Of $20 Million To $25 Million At The Closing Of The Proposed Mergers
Surface Oncology Inc reports results for the quarter ended in June - Earnings Summary
Brief: Surface Oncology, Inc. Q2 Net Income USD -28.2 Mln
Surface Oncology Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: ADAR1 Partners Reports 5.24% Passive Stake In Surface Oncology Inc As Of July 10 - SEC Filing